1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Therapeutic Enzymes Market, By Product Type
5.1 Introduction
5.2 Chitinase
5.3 Asparginase
5.4 Lipase
5.5 Protease
5.6 Nattokinase
5.7 Serratiopeptidase
5.8 Collagenase
5.9 Ligase
5.10 Other Product Types
6 Global Therapeutic Enzymes Market, By Application
6.1 Introduction
6.2 Leukemia
6.3 Stomach Disorders
6.4 Antitumor
6.5 Skin Ulcers
6.6 Gaucher disease
6.7 Fabry disease
6.8 Other Applications
7 Global Therapeutic Enzymes Market, End User
7.1 Introduction
7.2 Drug manufacturers
7.3 Hospitals
7.4 Private clinics
7.5 Research laboratories
8 Global Therapeutic Enzymes Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Sanofi
10.2 BioMarin
10.3 AbbVie
10.4 F. Hoffmann-La Roche Ltd
10.5 Thermo Fisher Scientific Inc.
10.6 Alexion
10.7 DSM
10.8 Novozymes
10.9 Horizon Pharma
10.10 Allergan
10.11 Johnson and Johnson
10.12 Alexion Pharmaceuticals Inc
10.13 Pfizer Inc.
10.14 Vivus, Digestive Care
10.15 Leadiant Biosciences
10.16 Roche Holdings AG
10.17 Codexis Inc.
List of Tables
Table 1 Global Therapeutic Enzymes Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 3 Global Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 4 Global Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 5 Global Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 6 Global Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 7 Global Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 8 Global Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 9 Global Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 10 Global Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 11 Global Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 12 Global Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 13 Global Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 14 Global Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 15 Global Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 16 Global Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 17 Global Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 18 Global Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 19 Global Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 20 Global Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 21 Global Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 22 Global Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 23 Global Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 24 Global Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 25 North America Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 26 North America Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 27 North America Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 28 North America Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 29 North America Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 30 North America Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 31 North America Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 32 North America Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 33 North America Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 34 North America Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 35 North America Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 36 North America Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 37 North America Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 38 North America Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 39 North America Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 40 North America Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 41 North America Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 42 North America Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 43 North America Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 44 North America Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 45 North America Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 46 North America Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 47 North America Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 48 North America Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 49 Europe Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 50 Europe Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 51 Europe Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 52 Europe Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 53 Europe Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 54 Europe Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 55 Europe Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 56 Europe Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 57 Europe Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 58 Europe Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 59 Europe Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 60 Europe Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 61 Europe Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 62 Europe Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 63 Europe Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 64 Europe Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 65 Europe Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 66 Europe Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 67 Europe Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 68 Europe Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 69 Europe Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 70 Europe Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 71 Europe Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 72 Europe Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 73 Asia Pacific Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 74 Asia Pacific Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 75 Asia Pacific Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 76 Asia Pacific Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 77 Asia Pacific Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 78 Asia Pacific Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 79 Asia Pacific Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 80 Asia Pacific Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 81 Asia Pacific Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 82 Asia Pacific Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 83 Asia Pacific Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 84 Asia Pacific Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 85 Asia Pacific Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 86 Asia Pacific Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 87 Asia Pacific Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 88 Asia Pacific Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 89 Asia Pacific Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 90 Asia Pacific Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 91 Asia Pacific Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 92 Asia Pacific Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 93 Asia Pacific Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 94 Asia Pacific Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 95 Asia Pacific Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 96 Asia Pacific Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 97 South America Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 98 South America Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 99 South America Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 100 South America Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 101 South America Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 102 South America Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 103 South America Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 104 South America Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 105 South America Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 106 South America Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 107 South America Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 108 South America Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 109 South America Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 110 South America Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 111 South America Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 112 South America Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 113 South America Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 114 South America Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 115 South America Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 116 South America Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 117 South America Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 118 South America Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 119 South America Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 120 South America Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 121 Middle East & Africa Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 122 Middle East & Africa Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 123 Middle East & Africa Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 124 Middle East & Africa Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 125 Middle East & Africa Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 126 Middle East & Africa Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 127 Middle East & Africa Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 128 Middle East & Africa Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 129 Middle East & Africa Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 130 Middle East & Africa Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 131 Middle East & Africa Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 132 Middle East & Africa Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 133 Middle East & Africa Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 134 Middle East & Africa Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 135 Middle East & Africa Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 136 Middle East & Africa Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 137 Middle East & Africa Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 138 Middle East & Africa Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 139 Middle East & Africa Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 140 Middle East & Africa Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 141 Middle East & Africa Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 142 Middle East & Africa Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 143 Middle East & Africa Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 144 Middle East & Africa Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
| ※参考情報 治療用酵素とは、特定の疾患の治療に使用される酵素のことを指します。これらの酵素は、体内での化学反応を促進する働きがあり、特に代謝異常や先天性疾患において重要な役割を果たします。治療用酵素は、患者の病気の原因となる物質を分解したり、特定の生理的機能を補完したりするために用いられます。 治療用酵素の種類には、主に以下のようなものがあります。まず、酵素補充療法に使用される酵素があります。これは、体内で不足している酵素を外部から補充するもので、多くの場合、遺伝的な疾患に関連しています。例えば、遺伝性の代謝異常症であるファブリー病やギャーシュ病には、それぞれ特定の酵素が必要であり、これらを補充することで症状の改善が期待できます。 次に、抗炎症作用を持つ酵素もあります。このような酵素は、炎症を引き起こす物質を分解する働きを持ち、治療に使用されることがあります。一例として、ウルソデオキシコール酸を含む酵素があり、肝疾患や胆道疾患の治療に用いられることがあります。 さらに、癌治療においても治療用酵素が利用されています。例えば、抗腫瘍作用を持つ酵素は、腫瘍細胞の増殖を抑えるために開発されています。これらの酵素は、腫瘍内の特定の基質をターゲットにして作用することで、癌細胞を選択的に攻撃します。 治療用酵素の用途は多岐にわたります。主な用途としては、患者の生活の質を向上させることや、症状を軽減することが挙げられます。例えば、酵素補充療法により、遺伝的な疾患に苦しむ患者は必要な酵素を補うことで、生活の質が大きく向上することがあります。また、抗炎症作用を持つ酵素を使用することで、慢性的な炎症に苦しむ患者が症状を緩和できる可能性もあります。 治療用酵素に関連する技術としては、バイオテクノロジーの進展が挙げられます。遺伝子組換え技術を用いることで、特定の酵素を大量に生産することが可能になりました。これにより、治療用酵素の供給が安定し、多くの患者に対して治療を提供できるようになっています。また、クリスパー技術などの遺伝子編集技術も、治療用酵素の研究や応用において重要な役割を果たしています。 さらに、治療用酵素を効果的に投与するためのドラッグデリバリーシステムも多く開発されています。これらのシステムは、酵素が体内で正確な場所に到達することを可能にし、効率的に作用するように設計されています。リポソームやナノ粒子を用いることで、酵素の安定性や生物学的利用能を向上させることが目的とされています。 治療用酵素は、今後の医療において非常に重要な役割を果たすと期待されています。新たな疾患に対する治療法としての可能性や、より効果的な投与方法の研究が進む中で、患者にとって有益な治療が提供されることが求められています。これにより、個々の患者に寄与する最適な治療用酵素の開発や、より多くの疾患に対して有効な治療法が見い出されることが期待されています。 このように、治療用酵素は医学の発展において重要な一翼を担っている存在であり、今後もその研究と応用は進むでしょう。治療用酵素に関する科学的理解が深まることで、さまざまな疾患に対する新たな治療戦略が生まれる可能性が広がっています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
-gr.jpg)
